These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 16006759)
1. The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation. Cheung CM; Tsoi TH; Huang CY Cerebrovasc Dis; 2005; 20(2):114-9. PubMed ID: 16006759 [TBL] [Abstract][Full Text] [Related]
2. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085 [TBL] [Abstract][Full Text] [Related]
3. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. Hylek EM; Skates SJ; Sheehan MA; Singer DE N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
5. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Agarwal S; Bennett D; Smith DJ Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933 [TBL] [Abstract][Full Text] [Related]
6. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy. Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439 [TBL] [Abstract][Full Text] [Related]
7. Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Odén A; Fahlén M; Hart RG Thromb Res; 2006; 117(5):493-9. PubMed ID: 16517250 [TBL] [Abstract][Full Text] [Related]
8. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation. Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study. Naganuma M; Shiga T; Sato K; Murasaki K; Hashiguchi M; Mochizuki M; Hagiwara N Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743 [TBL] [Abstract][Full Text] [Related]
10. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department. Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309 [TBL] [Abstract][Full Text] [Related]
11. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852 [TBL] [Abstract][Full Text] [Related]
12. Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital. Yousef ZR; Tandy SC; Tudor V; Jishi F; Trent RJ; Watson DK; Cowell RP Heart; 2004 Nov; 90(11):1259-62. PubMed ID: 15486116 [TBL] [Abstract][Full Text] [Related]
13. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. White HD; Gruber M; Feyzi J; Kaatz S; Tse HF; Husted S; Albers GW Arch Intern Med; 2007 Feb; 167(3):239-45. PubMed ID: 17296878 [TBL] [Abstract][Full Text] [Related]
14. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis. Agarwal S; Hachamovitch R; Menon V Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212 [TBL] [Abstract][Full Text] [Related]
15. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1. Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521 [TBL] [Abstract][Full Text] [Related]
16. Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand. Methavigul K; Boonyapisit W J Med Assoc Thai; 2014 Dec; 97(12):1274-80. PubMed ID: 25764634 [TBL] [Abstract][Full Text] [Related]
17. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients. Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057 [TBL] [Abstract][Full Text] [Related]
18. Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range? Lane DA; Lip GY Thromb Haemost; 2010 Feb; 103(2):254-6. PubMed ID: 20076858 [No Abstract] [Full Text] [Related]
19. [The efficiency and safety of anticoagulation therapy in atrial fibrillation in Chinese]. Sun YH; Hu DY Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):258-60. PubMed ID: 15130407 [TBL] [Abstract][Full Text] [Related]
20. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation. Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]